OUR SERVICES
Drug
Repurposing
-
Genomic signature based drug repurposing analyses have typically focused on the identification of compounds that reverse or reinforce a set of differentially expressed genes.
-
Our team performs systems-scale analyses that define disease on the basis of the global architecture and connectivity structure of the underlying gene networks.
-
We identify novel drug repurposing candidates that are predicted to target global changes in gene network patterns.

PERTH
AUSTRALIA
ARIZONA
UNITED STATES
Anthony Bosco
© 2021 Insigene Ltd. Site developed by NFIC Services.